Half-year report · Q2
6323.TEDINET S100UJ0W
Period2024-03-01 → 2024-08-31
Filed2024-10-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥60.2bn | 2024-03-01 → 2024-08-31 | Cons. | Net sales |
| Revenue | ¥93.2bn | 2023-03-01 → 2024-02-29 | Cons. | Net sales (5-year summary) |
| Revenue | ¥41.0bn | 2023-03-01 → 2023-08-31 | Cons. | Net sales |
| Operating income | ¥17.1bn | 2024-03-01 → 2024-08-31 | Cons. | Operating income |
| Operating income | ¥10.0bn | 2023-03-01 → 2023-08-31 | Cons. | Operating income |
| Ordinary income | ¥20.6bn | 2024-03-01 → 2024-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥27.1bn | 2023-03-01 → 2024-02-29 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.9bn | 2023-03-01 → 2023-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥20.6bn | 2024-03-01 → 2024-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥13.9bn | 2023-03-01 → 2023-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥15.8bn | 2024-03-01 → 2024-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥19.6bn | 2023-03-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.8bn | 2023-03-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥16.2bn | 2024-03-01 → 2024-08-31 | Cons. | Profit loss |
| Net income | ¥10.2bn | 2023-03-01 → 2023-08-31 | Cons. | Profit loss |
| Total assets | ¥184.7bn | at 2024-08-31 | Cons. | Assets |
| Total assets | ¥156.1bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥150.0bn | at 2023-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥60.5bn | at 2024-08-31 | Cons. | Liabilities |
| Total liabilities | ¥56.6bn | at 2024-02-29 | Cons. | Liabilities |
| Net assets / equity | ¥124.2bn | at 2024-08-31 | Cons. | Net assets |
| Net assets / equity | ¥99.5bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥90.1bn | at 2023-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥55.1bn | at 2024-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥38.0bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash & equivalents | ¥54.9bn | at 2024-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥38.0bn | at 2024-02-29 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥33.6bn | at 2023-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥28.3bn | at 2023-02-28d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥20.1bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥15.5bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.2bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.7bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.9bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.7bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥3.2bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥792m | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.8bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥89.97 | 2024-03-01 → 2024-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥111.11 | 2023-03-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.82 | 2023-03-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥89.85 | 2024-03-01 → 2024-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥110.91 | 2023-03-01 → 2024-02-29 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥55.72 | 2023-03-01 → 2023-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 60.6% | at 2024-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.1% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.3% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-03-01 → 2024-08-31 | −¥108m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-03-01 → 2024-08-31 | −¥108m |
| Reconciling Itemsreconciling | segment profit | 2024-03-01 → 2024-08-31 | −¥410m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | revenue | 2024-03-01 → 2024-08-31 | ¥334m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | revenue external | 2024-03-01 → 2024-08-31 | ¥334m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | segment profit | 2024-03-01 → 2024-08-31 | −¥52m |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue | 2024-03-01 → 2024-08-31 | ¥60.0bn |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue external | 2024-03-01 → 2024-08-31 | ¥59.9bn |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue intersegment | 2024-03-01 → 2024-08-31 | ¥108m |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | segment profit | 2024-03-01 → 2024-08-31 | ¥17.6bn |
| —segment total | revenue | 2024-03-01 → 2024-08-31 | ¥60.3bn |
| —segment total | revenue external | 2024-03-01 → 2024-08-31 | ¥60.2bn |
| —segment total | revenue intersegment | 2024-03-01 → 2024-08-31 | ¥108m |
| —segment total | segment profit | 2024-03-01 → 2024-08-31 | ¥17.6bn |
| Reconciling Itemsreconciling | revenue | 2023-03-01 → 2023-08-31 | −¥3m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-03-01 → 2023-08-31 | −¥3m |
| Reconciling Itemsreconciling | segment profit | 2023-03-01 → 2023-08-31 | −¥247m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | revenue | 2023-03-01 → 2023-08-31 | ¥152m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | revenue external | 2023-03-01 → 2023-08-31 | ¥152m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | segment profit | 2023-03-01 → 2023-08-31 | −¥97m |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue | 2023-03-01 → 2023-08-31 | ¥40.8bn |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue external | 2023-03-01 → 2023-08-31 | ¥40.8bn |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥3m |
| jpcrp040300-q2r_E02328-000Semiconductor And Liquid Crystalreportable segment | segment profit | 2023-03-01 → 2023-08-31 | ¥10.3bn |
| —segment total | revenue | 2023-03-01 → 2023-08-31 | ¥41.0bn |
| —segment total | revenue external | 2023-03-01 → 2023-08-31 | ¥41.0bn |
| —segment total | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥3m |
| —segment total | segment profit | 2023-03-01 → 2023-08-31 | ¥10.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 528
| Item | Context | Value | Unit |
|---|---|---|---|
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 5259000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 16962000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 28292000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 37951000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 33551000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 54913000000 | JPY |
| Directors compensations sga | Prior1YTDDuration | 285000000 | JPY |
| Directors compensations sga | CurrentYTDDuration | 316000000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 914000000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 1324000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 500000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 524000000 | JPY |
| Provision for directors bonuses sga | Prior1YTDDuration | -65000000 | JPY |
| Provision for directors bonuses sga | CurrentYTDDuration | -2000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 37000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 49000000 | JPY |
| Provision for directors retirement benefits sga | Prior1YTDDuration | 7000000 | JPY |
| Provision for directors retirement benefits sga | CurrentYTDDuration | 10000000 | JPY |
| Commission fee sga | Prior1YTDDuration | 524000000 | JPY |
| Commission fee sga | CurrentYTDDuration | 661000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 616000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 562000000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | 14000000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | 71000000 | JPY |
| Amortization of goodwill sga | Prior1YTDDuration | 128000000 | JPY |
| Amortization of goodwill sga | CurrentYTDDuration | 128000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 40839000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02328-000LifeScienceReportableSegmentsMember | 152000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 40992000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 40992000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 3000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02328-000LifeScienceReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 3000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -3000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 40843000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02328-000LifeScienceReportableSegmentsMember | 152000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 40995000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -3000000 | JPY |
| Net sales | Prior1YTDDuration | 40992000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 10297000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02328-000LifeScienceReportableSegmentsMember | -97000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 10200000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -247000000 | JPY |
| Operating income | Prior1YTDDuration | 9952000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 59895000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02328-000LifeScienceReportableSegmentsMember | 334000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 60229000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |